Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Intra-Abdominal Infections, including peritonitis, intra-abdominal abscess and liver abscess, caused by Bacteroides species including the B. fragilis group ( B. fragilis , B. distasonis , B. ovatus , B. thetaiotaomicron… US FDA label
Kidney dosing: Metronidazole (single-agent)Show full dosing details
- CrCl ≥60 mL/min
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
- CrCl 30–59 mL/min
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
- CrCl 15–29 mL/min
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label).
- CrCl <15 mL/min (not on dialysis)
- No dose change: kidney impairment does not alter single-dose metronidazole kinetics (label). In end-stage kidney disease, peak levels of hydroxy-metronidazole were 2 times and of metronidazole acetate 5 times normal (label PK). Because metabolites accumulate in end-stage kidney disease, monitoring for metronidazole-associated adverse events is recommended (label).
- Hemodialysis (intermittent)
- Hemodialysis (4 to 8 hours) removes 40% to 65% of a dose. If dosing cannot be separated from the session, consider a supplemental dose after hemodialysis (label).
- Peritoneal dialysis
- No dose change on CAPD; a 7.5-hour peritoneal dialysis removed about 10% of a dose (label).
- CRRT
- Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
- Dialyzable? Hemodialysis: yes (40% to 65% of a dose per 4- to 8-hour session, by membrane and duration). Peritoneal dialysis: little (about 10%) (label). Under 20% protein bound.
- Monitoring Neurologic symptoms (encephalopathy, cerebellar signs, seizures, peripheral or optic neuropathy, aseptic meningitis); liver function in hepatic impairment; INR with warfarin; lithium and creatinine with lithium (label).
From the Metronidazole monograph (renalcarematters.com, reviewed).
Use: Uses for the cure of most athlete's foot, jock itch and ringworm US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Vaginal suppository: 500 mg/100 mg, 750 mg/200 mg
Registered products in the Philippines
12 products registered with the Food and Drug Administration (FDA) Philippines list Metronidazole + Miconazole as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products12
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
InserdinMetronidazole + Miconazole nitrate | 750 mg/200 mg Vaginal SuppositoryPVC/PE Blister Strip x 7 (Box of 7’s) | Rx | Farmaprim S.R.L.Republic of Moldova | Medchoice Women’s Health (MCWH), Inc.Importer: Ambica International Corporation | DRP-8923-02 | Jun 24, 2030 | |
MetindazMetronidazole + Miconazole nitrate | 500 mg/100 mg Vaginal SuppositoryPVC/PE Blister Strip x 7 (Box of 14’s) | Rx | Farmaprim Ltd.Republic of Moldova | BSV Bioscience Phils. Inc.Importer: Ambica International Corporation | DRP-8924 | Jun 24, 2030 | |
Metindaz ForteMetronidazole + Miconazole nitrate | 750 mg/200 mg Vaginal SuppositoryPVC/PE Blister Strip x 7 (Box of 7’s) | Rx | Farmaprim Ltd.Republic of Moldova | BSV Bioscience Phils. Inc.Importer: Ambica International Corporation | DRP-8923 | Jun 24, 2030 | |
MetricoredMetronidazole + Miconazole nitrate | 500 mg/100 mg Vaginal SuppositoryPVC/PE Blister Strip x 7 (Box of 14’s) | Rx | Farmaprim S.R.L.Republic of Moldova | Red Drug Pharmaceutical Inc.Importer: Ambica International Corporation | DRP-8924-01 | Jun 24, 2030 | |
MetromicMetronidazole + Miconazole nitrate | 500 mg/100 mg Vaginal SuppositoryWhite PVC/PE Foil Strip x 7's Box of 14's | Rx | Kusum Healthcare Pvt. Ltd.India | Kusum Healthcare Private Limited Branch Office | DR-XY46750 | Oct 18, 2029 | |
Metromic ForteMetronidazole + Miconazole Nitrate | 750 mg/200 mg Vaginal SuppositoryWhite PVC/PE Foil Strip x 7's (Box of 7's) | Rx | Kusum Healthcare Private LimitedIndia | Kusum Healthcare Private Limited Branch Office | DR-XY46751 | Oct 18, 2029 | |
Micronida ForteMetronidazole + Miconazole nitrate | 750 mg/200 mg Vaginal SuppositoryPVC/PE Blister Strip x 7's (Box of 7’s) | Rx | Farmaprim Ltd.Republic of Moldova | Option One EnterpriseImporter: Ambica International Corporation | DRP-8923-01 | Jun 24, 2030 | |
Neo-PenotranMetronidazole + Miconazole Nitrate | 500 mg/100 mg Vaginal SuppositoryCasing Strip-PVC (Box of 14's) | Rx | Interphil Laboratories, Inc.Philippines | Trader: Exeltis International Philippines, Inc. | DRP-6648 | Sep 25, 2031 | |
Neo-PenotranMetronidazole + Miconazole Nitrate | 500mg / 100mg Vaginal SuppositoryPVC/PE Casing strip (Box of 14's) | Rx | Exeltis Ilac San. Ve Tic. A.S.Turkey | Embil International Philippines, Inc. | DRP-12796 | Oct 7, 2027 | |
Neo-Penotran ForteMetronidazole + Miconazole Nitrate | 750 mg/200 mg Vaginal SuppositoryCasing Strip - PVC/PE (box of 7's) | Rx | INTERPHIL LABORATORIES, INC.Philippines | Trader: EMBIL INTERNATIONAL PHILIPPINES, INC. | DR-XY33680 | Jul 30, 2027 | |
Neo-Penotran ForteMetronidazole + Miconazole Nitrate | 750mg / 200mg Vaginal SuppositoryPVC/PE Casing strip (Box of 7's) | Rx | Exeltis Ilac San. Ve Tic. A.S.Turkey | Embil International Philippines, Inc. | DRP-12795 | Oct 7, 2027 | |
TrimicMetronidazole + Miconazole nitrate | 500 mg/100 mg Vaginal SuppositoryPVC/PE foil strip x 7's (Box of 14's) | Rx | Bliss GVS Pharma LimitedIndia | UNILAB, Inc. | DR-XY45849 | Apr 11, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .